Expression of α-fetoprotein and albumin genes in human hepatocellular carcinomas: Limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy

Hepatology

Volumn 27, Issue 2, 1998, Pages 599-607

  Ohguchi, Souhei ^a   Nakatsukasa, Harushige ^a   Higashi, Toshihiro ^a   Ashida, Kozo ^a   Nouso, Kazuhiro ^a   Ishizaki, Masahiko ^a   Hino, Naoki ^a   Kobayashi, Yoshiyuki ^a   Uematsu, Shuji ^a   Tsuji, Takao ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA FETOPROTEIN;

ADULT; AGED; ARTICLE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER NODULE; MALE; NORTHERN BLOTTING; PRIORITY JOURNAL; STEM CELL; TRANSCRIPTION REGULATION;

ADULT; AGED; ALPHA-FETOPROTEINS; BLOTTING, NORTHERN; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; FEMALE; GENE THERAPY; HEPATITIS, CHRONIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIVER CIRRHOSIS; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; REGULATORY SEQUENCES, NUCLEIC ACID; RNA, MESSENGER; SERUM ALBUMIN;

EID: 17344374394     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510270239     Document Type: Article

References (9)

1. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-699.
2. Huber BE, Richards CA, Krenitsky TA. Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: an innovative approach for cancer therapy. Proc Natl Acad Sci U S A 1991;88:8039-8043.
3. Ido A, Nakata K, Kalo Y, Nakao K, Murata K, Fujita M, Ishii N, et al. Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter. Cancer Res 1995;55:3105-3109.
4. Kaneko S, Hallenbeck P, Kotani T, Nakabayashi H, McGarrity G, Tamaoki T, Anderson WE, et al. Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression. Cancer Res 1995;55:5283-5287.
5. Kanai F, Shiratori Y, Yoshida Y, Wakimoto H, Hamada H, Kanegae Y, Saito I, et al. Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene. HEPATOLOGY 1996;23:1359-1368.
6. Macri P, Gordon JW. Delayed morbidity and mortality of albumin/SV40 T-antigen transgenic mice after insertion of an alpha-fetoprotein/herpes virus thymidine kinase transgene and treatment with ganciclovir. Hum Gene Ther 1994;5:175-182.
7. Kuriyama S, Yoshikawa M, Ishizaka S, Tsujii T, Ikenaka K, Kagawa T, Morita N, et al. A potential approach for gene therapy targeting hepatoma using a liver-specific promoter on a retrovirus vector. Cell Struct Funct 1991;16:503-510.
8. Arbuthnot P, Bralet MP, Thomassin H, Danan JL, Brechet C, Ferry N. Hepatoma cell-specific expression of a retrovirally transferred gene is achieved by alpha-fetoprotein but not insulin like growth factor II regulatory sequences. HEPATOLOGY 1995;22:1788-1796.
9. Ruoslahti E, Seppala M. Alpha-fetoprotein in cancer and fetal development. Adv Cancer Res 1979;29:275-346.